Balyasny Asset Management
ABOS icon

Balyasny Asset Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Balyasny Asset Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-63,949
Closed -$259K – 1870
2024
Q1 		$259K Buy
63,949
+43,371
+211% +$176K ﹤0.01% 1704
2023
Q4 		$79K Buy
+20,578
New +$79K ﹤0.01% 1825
2023
Q3 		– Sell
-30,222
Closed -$145K – 1719
2023
Q2 		$145K Buy
+30,222
New +$145K ﹤0.01% 1698